These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 1907023)

  • 21. Rotation evoked by nigral stimulation following lateral hypothalamic, striatal, pallidal lesions in rats.
    Saranak J; Goldfarb J
    Exp Neurol; 1982 Aug; 77(2):295-313. PubMed ID: 6807706
    [No Abstract]   [Full Text] [Related]  

  • 22. Quantification of lesion-induced dopaminergic supersensitivity using the rotational model in the mouse.
    Mandel RJ; Randall PK
    Brain Res; 1985 Mar; 330(2):358-63. PubMed ID: 3921193
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lesions of the dopaminergic nigrostriatal system in neonatal rats: effects on the electrophysiological activity of striatal neurons recorded during adulthood.
    Onn SP; Balzer JR; Sidney JP; Stricker EM; Zigmond MJ; Berger TW
    Brain Res; 1990 Jun; 518(1-2):274-8. PubMed ID: 2117988
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dopamine D2 receptor control of pallidal fos expression: comparisons between intact and 6-hydroxydopamine-treated hemispheres.
    Marshall JF; Cole BN; LaHoste GJ
    Brain Res; 1993 Dec; 632(1-2):308-13. PubMed ID: 7908600
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-dopaminergic nigrostriatal pathway.
    Guyenet PG; Crane JK
    Brain Res; 1981 Jun; 213(2):291-305. PubMed ID: 7248760
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The rotational behavior model: asymmetry in the effects of unilateral 6-OHDA lesions of the substantia nigra in rats.
    Robinson TE; Becker JB
    Brain Res; 1983 Mar; 264(1):127-31. PubMed ID: 6405975
    [No Abstract]   [Full Text] [Related]  

  • 27. Long-term survival of grafted cells, dopamine synthesis/release, synaptic connections, and functional recovery after transplantation of fetal nigral cells in rats with unilateral 6-OHDA lesions in the nigrostriatal dopamine pathway.
    Nishino H; Hashitani T; Kumazaki M; Sato H; Furuyama F; Isobe Y; Watari N; Kanai M; Shiosaka S
    Brain Res; 1990 Nov; 534(1-2):83-93. PubMed ID: 1981488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased dopamine release from striata of rats after unilateral nigrostriatal bundle damage.
    Zhang WQ; Tilson HA; Nanry KP; Hudson PM; Hong JS; Stachowiak MK
    Brain Res; 1988 Oct; 461(2):335-42. PubMed ID: 3141002
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Visualization of multiple opioid-receptor types in rat striatum after specific mesencephalic lesions.
    Eghbali M; Santoro C; Paredes W; Gardner EL; Zukin RS
    Proc Natl Acad Sci U S A; 1987 Sep; 84(18):6582-6. PubMed ID: 2819882
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of neurotensin-containing neurons in the rat striatum and substantia nigra. Effects of unilateral nigral lesion with 6-hydroxydopamine on neurotensin content and its binding site density.
    Masuo Y; Pélaprat D; Montagne MN; Scherman D; Rostène W
    Brain Res; 1990 Mar; 510(2):203-10. PubMed ID: 1970504
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of dopamine-depleting brain lesions on the electrophysiological activity of rat substantia nigra dopamine neurons.
    Hollerman JR; Grace AA
    Brain Res; 1990 Nov; 533(2):203-12. PubMed ID: 2126975
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intrastriatal quinolinic acid injections protect against 6-hydroxydopamine-induced lesions of the dopaminergic nigrostriatal system.
    Venero JL; Romero-Ramos M; Revuelta M; Machado A; Cano J
    Brain Res; 1995 Feb; 672(1-2):153-8. PubMed ID: 7749737
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Striatonigral projection neurons contain D1 dopamine receptor-activated c-fos.
    Robertson GS; Vincent SR; Fibiger HC
    Brain Res; 1990 Jul; 523(2):288-90. PubMed ID: 2144781
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Parallel increases in striatal glutamic acid decarboxylase activity and mRNA levels in rats with lesions of the nigrostriatal pathway.
    Segovia J; Tillakaratne NJ; Whelan K; Tobin AJ; Gale K
    Brain Res; 1990 Oct; 529(1-2):345-8. PubMed ID: 2126483
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Messenger RNAs encoding glutamate-decarboxylases are differentially affected by nigrostriatal lesions in subpopulations of striatal neurons.
    Soghomonian JJ; Gonzales C; Chesselet MF
    Brain Res; 1992 Mar; 576(1):68-79. PubMed ID: 1515913
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dopamine-independent motor behavior following microinjection of rimorphin in the substantia nigra.
    Matsumoto RR; Lohof AM; Patrick RL; Walker JM
    Brain Res; 1988 Mar; 444(1):67-74. PubMed ID: 2896062
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Catecholamine-metabolizing enzyme activity in the nigrostriatal system.
    Francis A; Whittemore R; Jeffery DR; Pearce LB; Roth JA
    Biochem Pharmacol; 1987 Jul; 36(13):2229-31. PubMed ID: 3111478
    [No Abstract]   [Full Text] [Related]  

  • 38. Biochemical and immunocytochemical changes induced by intrastriatal 6-hydroxydopamine injection in the rat nigrostriatal dopamine neuron system: evidence for cell death in the substantia nigra.
    Ichitani Y; Okamura H; Nakahara D; Nagatsu I; Ibata Y
    Exp Neurol; 1994 Dec; 130(2):269-78. PubMed ID: 7867756
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unilateral destruction of dopamine pathways increases ipsilateral striatal serotonin turnover in rats.
    Karstaedt PJ; Kerasidis H; Pincus JH; Meloni R; Graham J; Gale K
    Exp Neurol; 1994 Mar; 126(1):25-30. PubMed ID: 7512513
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of L-dopa on in vivo dopamine release from nigrostriatal bundle neurons.
    Keller RW; Kuhr WG; Wightman RM; Zigmond MJ
    Brain Res; 1988 Apr; 447(1):191-4. PubMed ID: 3382951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.